Displaying drugs 7501 - 7525 of 13635 in total
beta-D-glucuronic acid
Experimental
Cefsulodin
Experimental
Matched Categories: … Antibacterials for Systemic Use ... Antiinfectives for Systemic Use …
Cefazedone
Experimental
Matched Categories: … Antibacterials for Systemic Use ... Antiinfectives for Systemic Use …
NP-51
Investigational
Macozinone
Macozinone is under investigation in clinical trial NCT03036163 (Phase 1 Study of PBTZ169).
Investigational
Matched Description: … Macozinone is under investigation in clinical trial NCT03036163 (Phase 1 Study of PBTZ169). …
Matched Categories: … Drugs for Treatment of Tuberculosis …
Matched Categories: … Drugs for Treatment of Tuberculosis …
Beinaglutide
Beinaglutide is under investigation in clinical trial NCT03829891 (Study for Beinaglutide Versus Glargine Therapy in Glycemic Variability of Type 2 Diabetes Mellitus).
Investigational
Matched Description: … Beinaglutide is under investigation in clinical trial NCT03829891 (Study for Beinaglutide Versus Glargine ... Therapy in Glycemic Variability of Type 2 Diabetes Mellitus). …
Matched Categories: … Drugs Used in Diabetes …
Matched Categories: … Drugs Used in Diabetes …
IR502
IR502 (Zorcell) is a potential treatment for psoriasis.
Investigational
Matched Description: … IR502 (Zorcell) is a potential treatment for psoriasis. …
Linerixibat
GSK2330672 has been investigated for the treatment of Diabetes Mellitus, Type 2.
Investigational
Matched Description: … GSK2330672 has been investigated for the treatment of Diabetes Mellitus, Type 2. …
acetylleucyl-leucyl-norleucinal
Experimental
Imidafenacin
Imidafenacin is an antispasmodic agent with anticholinergic effects. It antagonizes muscarinic receptors in the bladder to reduce the frequency of urination in the treatment of overactive bladder. It is marketed in Japan under the tradenames Staybla by Ono Pharmaceutical and Uritos by Kyojin Pharmaceutical.
Investigational
Matched Description: … It antagonizes muscarinic receptors in the bladder to reduce the frequency of urination in the treatment ... It is marketed in Japan under the tradenames Staybla by Ono Pharmaceutical and Uritos by Kyojin Pharmaceutical …
Matched Categories: … Drugs for Urinary Frequency and Incontinence …
Matched Categories: … Drugs for Urinary Frequency and Incontinence …
Lobeline
An alkaloid that has actions similar to nicotine on nicotinic cholinergic receptors but is less potent. It has been proposed for a variety of therapeutic uses including in respiratory disorders, peripheral vascular disorders, insomnia, and smoking cessation. [PubChem]
Investigational
Matched Description: … It has been proposed for a variety of therapeutic uses including in respiratory disorders, peripheral …
Idraparinux
Idraparinux, a synthetic pentasaccharide is an antithrombin-dependent inhibitor of activated factor X. It was developed for the treatment and prevention of thromboembolic events. However, clinical trials have revealed that idraparinux had lead to bleeding. As a result, Sanofi stopped the development of the drug.
Investigational
Matched Description: … It was developed for the treatment and prevention of thromboembolic events. ... As a result, Sanofi stopped the development of the drug. ... Idraparinux, a synthetic pentasaccharide is an antithrombin-dependent inhibitor of activated factor X …
N(2)-(2-carboxyethyl)-L-arginine
Experimental
Carmegliptin
Carmegliptin has been used in trials studying the treatment of Diabetes Mellitus Type 2.
Investigational
Matched Iupac: … (4S)-1-[(2S,3S,11bS)-2-amino-9,10-dimethoxy-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-3-yl]-4-( …
Matched Description: … Carmegliptin has been used in trials studying the treatment of Diabetes Mellitus Type 2. …
Matched Description: … Carmegliptin has been used in trials studying the treatment of Diabetes Mellitus Type 2. …
pGM169/GL67A
Investigational
LC16M8
LC16m8 is a next-generation, attenuated smallpox vaccine that is designed to have a better safety profile, yet be equally effective, compared to conventional smallpox vaccines. It is the only attenuated vaccine to be licensed for use in humans to prevent smallpox infection.
Investigational
Matched Description: … It is the only attenuated vaccine to be licensed for use in humans to prevent smallpox infection. ... LC16m8 is a next-generation, attenuated smallpox vaccine that is designed to have a better safety profile …
GLPG-0259
GLPG-0259 is under investigation in clinical trial NCT01024517 (GLPG0259 Solid Formulation Bioavailability and Food Effect).
Investigational
Matched Iupac: … 8-({4-[(1S,4S)-5-(propan-2-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]phenyl}amino)-[1,2,4]triazolo[1,5-a] …
Matched Description: … GLPG-0259 is under investigation in clinical trial NCT01024517 (GLPG0259 Solid Formulation Bioavailability …
Matched Description: … GLPG-0259 is under investigation in clinical trial NCT01024517 (GLPG0259 Solid Formulation Bioavailability …
anti-OX40 antibody BMS 986178
A macrocyclic peptide (BMS-986189) with activity in binding and functional assays comparable to a PD-L1 antibody.
Investigational
Matched Description: … A macrocyclic peptide (BMS-986189) with activity in binding and functional assays comparable to a PD-L1 …
Sesame oil
Sesame oil is a commonly used vegetable oil in Asia and flavoring enhancer in various culinary practices. It is extracted from sesame seeds and contains linoleic acid, oleic acid, palmitic acid, stearic acid and other fatty acids. Sesame oil is reported to possess antioxidant, antiaging, antihypertensive, immunoregulatory and anticancer properties....
Investigational
Nutraceutical
Matched Description: … Sesame oil is a commonly used vegetable oil in Asia and flavoring enhancer in various culinary practices ... It has also shown to accelerate alcohol decomposition in the liver [A27257]. ... Sesame oil is considered an indirect additive used in food cotact substances by the FDA. …
5-hydroxyvaleric acid
Experimental
Br-Coeleneterazine
Experimental
Matched Iupac: … 2S,8S)-8-benzyl-2-[(4-bromophenyl)methyl]-2-hydroperoxy-6-(4-hydroxyphenyl)-2H,3H,7H,8H-imidazo[1,2-a] …
Dehydroemetine
Investigational
Matched Iupac: … (1R)-1-{[(11bS)-3-ethyl-9,10-dimethoxy-1H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-yl]methyl}-6,7-dimethoxy …
MIV-701
MIV-701 is a selective, potent inhibitor of the protease Cathepsin K. It is developed for the treatment of osteoporosis.
Investigational
Matched Description: … It is developed for the treatment of osteoporosis. ... MIV-701 is a selective, potent inhibitor of the protease Cathepsin K. …
Filibuvir
Filibuvir has been used in trials studying the treatment of Hepatitis, Hepatitis C, and Chronic Hepatitis C.
Investigational
Matched Iupac: … (6R)-6-cyclopentyl-6-[2-(2,6-diethylpyridin-4-yl)ethyl]-3-({5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin …
Matched Description: … Filibuvir has been used in trials studying the treatment of Hepatitis, Hepatitis C, and Chronic Hepatitis …
Matched Description: … Filibuvir has been used in trials studying the treatment of Hepatitis, Hepatitis C, and Chronic Hepatitis …
Displaying drugs 7501 - 7525 of 13635 in total